🇺🇸 FDA
Patent

US 7009050

5-Substituted pyrimidine derivatives of conformationally locked nucleoside analogues

expired A61PA61P31/12A61P31/22

Quick answer

US patent 7009050 (5-Substituted pyrimidine derivatives of conformationally locked nucleoside analogues) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61P, A61P31/12, A61P31/22